IHI News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

IH

Volume

5.73M

Loading chart

IH

IHIiShares U.S. Medical Devices ETF

IHI

Pay with—

Available Balance0.00

IH

AUM

N/A

Volume

5.73M

Yield

0.60%

Chart Earnings News About Dividends Insider Filings

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?The iShares U.S. Medical Devices ETF (IHI) is reviewed as a passively managed fund offering diversified exposure to the healthcare medical devices sector. With $3.44 billion in assets and a 0.37% expense ratio, IHI tracks the Dow Jones U.S. Select Medical Equipment Index. The fund has declined 12.46% year-to-date and carries a Zacks ETF Rank of 3 (Hold), making it a reasonable but not exceptional choice for sector exposure.Zacks Investment Research · Sep 2, 2026

Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026Becton, Dickinson and Company received FDA 510(k) clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System, with market launch expected in early 2026. The advanced system features high and low vacuum strengths, 360-degree sampling ability, and multiple probe options. However, analysts expect slightly lower earnings and revenue compared to the prior year quarter, and the stock is considered overvalued despite a consensus Buy rating.Benzinga · Jan 15, 2026

Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate ThrombectomyBoston Scientific agreed to acquire thrombectomy specialist Penumbra for $14.5 billion ($374 per share) in a cash-and-stock deal. Penumbra shareholders will receive approximately 73% cash and 27% equity. The acquisition allows Boston Scientific to enter fast-growing vascular segments. Penumbra reported strong preliminary Q4 2025 results with 21-24% revenue growth. Boston Scientific expects 6-8 cents per share dilution in year one, trending toward neutral to accretive thereafter. The deal is expected to close in 2026.Benzinga · Jan 15, 2026

Samsung's Xealth Acquisition Connects Patient Data To Clinical CareSamsung Electronics plans to acquire Xealth, a digital health platform, to integrate wearable device data with hospital systems, enhancing personalized healthcare and advancing its digital health strategy.Benzinga · Jul 8, 2025

Healthcare Sector Setting Up for a Catch-Up Trade in H2?The healthcare sector has faced several headwinds in 2025, leading to lower earnings growth expectations. However, the sector is still expected to be one of the strongest performers in the S&P 500 this year, and some individual stocks and ETFs have shown resilience.Investing.com · Jun 2, 2025

Trump Again Promises Lower Drug Prices By 'Cutting Out Middlemen' Like UnitedHealth, CVS: Will It Work This Time?President Trump signed an executive order aimed at reducing prescription drug prices in the U.S. by tying them to the lowest prices paid in other countries. However, legal experts have raised concerns about the legality of the order, and it may face similar challenges as a previous attempt in 2020.Benzinga · May 13, 2025

Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?Sector ETF report for XHEZacks Investment Research · Jun 24, 2024

Want to Earn More in the Stock Market With Less Effort? Try This Simple StrategyYou don't need to be a stock market expert to earn above-average returns.The Motley Fool · Jun 22, 2024

5 Sector ETFs & Stocks to Benefit From May Inflation ReportUS annual inflation rate slowed to 3.3% in May 2024, the lowest in three months, compared to 3.4% in April and forecasts of 3.4%.Zacks Investment Research · Jun 13, 2024

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?Sector ETF report for IHIZacks Investment Research · Jun 3, 2024

to start trading

IH

IHIiShares U.S. Medical Devices ETF

IHI

Pay with—

Available Balance0.00

Your PositionYou don't own any IHI yet.

Related Tickers

Earnings

Dividends

Last · Sep 15Quarterly

Amount$0.0810

Yield0.49%

Annual$0.26